MS: Busting the Myths
May 29, 2024 | Life with MS, News, Progressive, Treatments
On Wednesday 15 May, Multiple Sclerosis NZ raised how critical workforce shortages are impacting patients with Primary Progressive MS (PPMS) access to time sensitive disease modifying therapies. A business case prepared by clinical specialists had been under review for five […]
May 15, 2024 | Advocacy, Funding, Life with MS, Media, News, Press Release, Treatments
A celebrated Pharmac decision late last year to fund a vital drug for many Multiple Sclerosis patients has fallen flat – with dozens being turned away for treatment due to severely stretched resources across a number of services. Multiple Sclerosis […]
September 14, 2023 | Treatments
Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here: PPMS Ocrevus FAQ – 13 September 2023. What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)? There is only […]
September 4, 2023 | Advocacy, Media, Progressive, Treatments
A seven year battle on behalf of hundreds of people living with the most debilitating form of Multiple Sclerosis has been won – with Pharmac agreeing to fund Aotearoa New Zealand’s first ever treatment for the disease variant from October […]
June 22, 2023 | Advocacy, Funding, Media, Progressive
Multiple Sclerosis New Zealand (MSNZ) is delighted to share that Pharmac have commenced consultation to fund Ocrelizumab for Primary Progressive MS. Currently, those with PPMS have no access to any disease modifying therapies. Ocrelizumab has been proven in trials to […]